Dr. Thomas Scott Shane, MD

Dr. Shane practices at Shane Retina, P.A. in Sarasota, Florida.

Dr. Shane's NPI, 1285826024, was assigned on August 15, 2007. Dr. Shane graduated from WashU Medicine in 2006. Dr. Shane holds Florida license ME106610.

Dr. Shane's primary practice is Shane Retina, P.A., at 3550 S Tamiami Trl, Sarasota, FL 34239 in Sarasota County. The practice phone is (941) 351-1200.

Dr. Shane's primary practice is Shane Retina, P.A. in Sarasota, Florida. Dr. Shane is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. Dmand AI also links Dr. Shane to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shane practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Shane's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Shane is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Shane is licensed in Florida.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Shane treats.

CMS data shows 187,700 Medicare services from Dr. Shane across 33 procedure codes in 2024, for 2,721 Medicare patients. Medicare paid $7,737,979 for them.

CMS counts 2,721 Medicare patients who saw Dr. Shane in 2024. The largest group is 75 to 84, with 1,135 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shane's median patient age at 76, with 55% women.

In 2024, Dr. Shane wrote 1,502 Medicare Part D claims for 542 patients. 56% of them were for generic drugs. CMS names the drug for 1,412 of them, across 19 drugs with 11 or more claims each, at $101,679 in total drug cost. In 2023, CMS named 1,057 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Shane for performance year 2024, reported as part of a group. Dr. Shane accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 79 procedures of cataract surgery by Dr. Shane, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Shane, published from 2011 to 2018. 2011 was the busiest year, with 3. The most frequent topics are Visual Acuity, Endophthalmitis and Eyeglasses. Dr. Shane has published most often in Ophthalmic Surg Lasers Imaging. Dr. Shane's most frequent co-authors are Richard K. Lee, MD, PhD, Eduardo Alfonso, MD and Andrew S. Camp, MD.

CMS Open Payments shows 5 general payments to Dr. Shane from 3 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Dutch Ophthalmic, USA paid the most, $131.

Dmand AI lists 1 award for Dr. Shane, most recently Outstanding Research in Residency in 2010.

Dr. Shane graduated from WashU Medicine in 2006.

Dr. Shane is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.